Gail D'Onofrio1, Linda C Degutis. 1. Department of Emergency Medicine, Yale University School of Medicine, New Haven, CT, USA. gail.donofrio@yale.edu
Abstract
OBJECTIVES: The objective was to evaluate the effects of Project Alcohol and Substance Abuse Services Education and Referral to Treatment (ASSERT), an emergency department (ED)-based screening, brief intervention, and referral to treatment program for unhealthy alcohol and other drug use. METHODS: Health promotion advocates (HPAs) screened ED patients for alcohol and/or drug problems 7 days a week using questions embedded in a general health questionnaire. Patients with unhealthy drinking and/or drug use received a brief negotiation interview (BNI), with the goal of reducing alcohol/drug use and/or accepting a referral to a specialized treatment facility (STF), depending on severity of use. Patients referred to an STF were followed up at 1 month by phone or contact with the STF to determine referral completion and enrollment into the treatment program. RESULTS: Over a 5-year period (December 1999 through December 2004), 22,534 adult ED patients were screened. A total of 10,246 (45.5%) reported alcohol consumption in the past 30 days, of whom 5,533 (54%) exceeded the National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines for low-risk drinking. Use of at least one illicit drug was reported by 3,530 patients (15.7%). Over one-fourth of screened patients received BNIs (6,266, or 27.8%). Of these, 3,968 (63%) were referred to an STF. Eighty-three percent of patients were followed at 1 month, and 2,159 (65%) had enrolled in a program. Patients who received a direct admission to an STF were 30 times more likely to enroll than those who were indirectly referred (odds ratio = 30.71; 95% confidence interval = 18.48 to 51.04). After 3 years, funding for Project ASSERT was fully incorporated into the ED budget. CONCLUSIONS: Project ASSERT has been successfully integrated into an urban ED. A direct, facilitated referral for patients with alcohol and other drug problems results in a high rate of enrollment in treatment programs.
OBJECTIVES: The objective was to evaluate the effects of Project Alcohol and Substance Abuse Services Education and Referral to Treatment (ASSERT), an emergency department (ED)-based screening, brief intervention, and referral to treatment program for unhealthy alcohol and other drug use. METHODS: Health promotion advocates (HPAs) screened ED patients for alcohol and/or drug problems 7 days a week using questions embedded in a general health questionnaire. Patients with unhealthy drinking and/or drug use received a brief negotiation interview (BNI), with the goal of reducing alcohol/drug use and/or accepting a referral to a specialized treatment facility (STF), depending on severity of use. Patients referred to an STF were followed up at 1 month by phone or contact with the STF to determine referral completion and enrollment into the treatment program. RESULTS: Over a 5-year period (December 1999 through December 2004), 22,534 adult ED patients were screened. A total of 10,246 (45.5%) reported alcohol consumption in the past 30 days, of whom 5,533 (54%) exceeded the National Institute on Alcohol Abuse and Alcoholism (NIAAA) guidelines for low-risk drinking. Use of at least one illicit drug was reported by 3,530 patients (15.7%). Over one-fourth of screened patients received BNIs (6,266, or 27.8%). Of these, 3,968 (63%) were referred to an STF. Eighty-three percent of patients were followed at 1 month, and 2,159 (65%) had enrolled in a program. Patients who received a direct admission to an STF were 30 times more likely to enroll than those who were indirectly referred (odds ratio = 30.71; 95% confidence interval = 18.48 to 51.04). After 3 years, funding for Project ASSERT was fully incorporated into the ED budget. CONCLUSIONS: Project ASSERT has been successfully integrated into an urban ED. A direct, facilitated referral for patients with alcohol and other drug problems results in a high rate of enrollment in treatment programs.
Authors: Li-Tzy Wu; Marvin S Swartz; Zunyou Wu; Paolo Mannelli; Chongming Yang; Dan G Blazer Journal: Ann Emerg Med Date: 2012-03-15 Impact factor: 5.721
Authors: Douglas Zatzick; Dennis Donovan; Christopher Dunn; Joan Russo; Jin Wang; Gregory Jurkovich; Frederick Rivara; Lauren Whiteside; Richard Ries; Larry Gentilello Journal: J Subst Abuse Treat Date: 2012-09-19
Authors: Michael V Pantalon; Steve Martino; James Dziura; Fang-Yong Li; Patricia H Owens; David A Fiellin; Patrick G O'Connor; Gail D'Onofrio Journal: J Subst Abuse Treat Date: 2012-09-26
Authors: Kei Ouchi; Naomi George; Anna C Revette; Mohammad Adrian Hasdianda; Lauren Fellion; Audrey Reust; Lynda H Powell; Rebecca Sudore; Jeremiah D Schuur; Mara A Schonberg; Edward Bernstein; James A Tulsky; Susan D Block Journal: J Palliat Med Date: 2018-11-12 Impact factor: 2.947
Authors: Kipling M Bohnert; Maureen A Walton; Stella Resko; Kristen T Barry; Stephen T Chermack; Robert A Zucker; Marc A Zimmerman; Brenda M Booth; Frederic C Blow Journal: Am J Drug Alcohol Abuse Date: 2013-11-12 Impact factor: 3.829
Authors: Gail D'Onofrio; Patrick G O'Connor; Michael V Pantalon; Marek C Chawarski; Susan H Busch; Patricia H Owens; Steven L Bernstein; David A Fiellin Journal: JAMA Date: 2015-04-28 Impact factor: 56.272
Authors: Federico E Vaca; James Dziura; Fuad Abujarad; Michael V Pantalon; Allen Hsiao; Craig A Field; Gail D'Onofrio Journal: Contemp Clin Trials Date: 2020-09-16 Impact factor: 2.226
Authors: Tamara M Haegerich; Linda L Dahlberg; Thomas R Simon; Grant T Baldwin; David A Sleet; Arlene I Greenspan; Linda C Degutis Journal: Lancet Date: 2014-07-01 Impact factor: 79.321